Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Just thought I would pass this along

<< Previous

Bullboard Posts

Next >>

Comment by Wino115on Mar 01, 2021 4:30pm

75 Views

Post# 32688020

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Just thought I would pass this along

I think you know the answer. He doesn't believe in stock options.

scarlet1967 wrote: I wonder how much warren Buffet pays himself or has paid himself during last few decades??
Has he been granting options to himself over the years or let the money stay in the company?

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale